H.M.’s Brain, 1953–Present

A temporal lobectomy led to profound memory impairment in a man who became the subject of neuroscientists for the rest of his life—and beyond.

Written byRina Shaikh-Lesko
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

THE SCARS THAT TAUGHT US: The ventral side of H.M.’s brain shows evidence of the surgical scars left by William Beecher Scoville’s 1956 surgery (A and B), which removed portions of the medial temporal lobe, including much of the hippocampus. Also visible is a mark left by one of the surgical clips (C). During the post-mortem analysis, examiners found an unexpected lesion in the orbitofrontal region (D). The portion of H.M.’s hippocampus that remained after the surgery is not visible in this image. (Scale bar, 1 cm)THE BRAIN OBSERVATORY, JACOPO ANNESEIn 1953, William Beecher Scoville performed an experimental procedure on a 27-year-old man who had exhausted all other medical options for treating his severe epilepsy. A medial temporal lobe resection removed most of the patient’s hippocampus, along with pieces of neighboring regions. It succeeded in nearly eliminating the seizures, but left the young man without the ability to form any new memories.

For the next half century, that patient, known as H.M., would become the most studied man in neuroscience. His memory dysfunction helped neuroscientists understand the critical role the hippocampus plays in receiving, processing, and consolidating sensory input. Nearly 100 researchers have studied him, including Suzanne Corkin, who met H.M. in 1962 when she was a graduate student and went on to work closely with him for nearly five decades. Now a professor emerita at MIT, Corkin describes her long-time subject as gentle, intelligent, and gregarious. It was not until 2008, when he died at 82, that H.M.’s identity and real name, Henry Gustave Molaison, was revealed to the world.

On the night Molaison died, doctors set in motion a plan arranged years in advance to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies